Depura

Quick links to important sections

Depura

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Depura

Quick Facts

Property Description
Active Ingredient Cholecalciferol (Vitamin D3)
Form Soft-gelatin capsules, oral solution, tablets, drops
Pharmacological Class Vitamin; Anti-rachitic agent
Common Use Maintaining calcium and phosphate balance
Origin Secosteroid derivative; synthetic or derived from natural sources

What is the Medicinal Class and Identity of Depura?

Depura is the pharmaceutical designation for preparations containing Cholecalciferol, commonly known as Vitamin D3. It is fundamentally classified as an essential nutrient and a lipid-soluble vitamin, belonging to the high-level pharmacological class of an anti-rachitic agent. Cholecalciferol is vital for the absorption of calcium, a necessity widely recognized for skeletal health.

This substance is technically considered a prohormone, a characteristic that sets it apart from simple mineral supplements, as the body must process it through specific hydroxylation steps in the liver and kidneys to convert it into its active hormone form, Calcitriol. This regulatory action positions Depura as a critical agent in the body’s endocrine signaling system dedicated to calcium-regulating processes.

Composition, Origin, and Forms of Cholecalciferol

Depura is typically formulated as a single-ingredient product, where the active substance, Cholecalciferol, is often suspended in a lipid-based vehicle, such as specialized oils. This oily composition is necessary due to the compound's inherent fat-soluble nature, which aids its proper assimilation in the digestive tract.

The preparation is available for oral administration in a variety of high-level dosage forms, including soft-gelatin capsules, conventional tablets, and drops. Vitamin D3 is effective for maintaining sufficient serum concentrations of the compound.

What is the General Purpose of Depura?

The general purpose of Depura is to ensure the body can effectively promote the intestinal absorption of calcium and phosphate from the food consumed. This primary function is crucial for securing the mineral supply needed for systemic health and directly supports the process of mineralization of bone.

For instance, it is typically used to help maintain bone density over the long term. By stabilizing the supply of these essential minerals, Depura assists in maintaining the structural integrity and strength of the skeletal system, which is vital not only for bone health but also for the proper function of neuromuscular processes.

What side effects are possible with Depura?

Possible Side Effects and Safety Information

The safety information for Depura (cholecalciferol) is based strictly on regulatory documents and focuses on adverse reactions and limitations of use.

Known Adverse Reactions

The following side effects have been reported, categorized by their officially documented frequency:

  • Uncommon (Affects 1 to 10 users in 1,000): Hypercalcaemia (elevated blood calcium levels) and Hypercalciuria (excess calcium in the urine).
  • Rare (Affects 1 to 10 users in 10,000): Allergic reactions, including pruritus (itching), rash, urticaria (hives), and hypersensitivity reactions.
  • Frequency Not Known: Gastrointestinal symptoms such as nausea, vomiting, loss of appetite, constipation, and a metallic taste. Other general symptoms may include weakness, fatigue, headache, sleepiness, and dry mouth.

Serious Safety Concerns and Contraindications

The most serious risk associated with this medicine is Hypervitaminosis D (Vitamin D toxicity), which results from high, prolonged exposure. This condition can lead to severe complications, including nephrocalcinosis (calcium deposits in the kidney), renal failure, and hypertension (high blood pressure). This toxicity is generally reversible upon stopping treatment, unless permanent kidney damage has occurred.

Depura is strictly contraindicated (should not be used) in patients with:

  • Hypersensitivity to cholecalciferol or related substances.
  • Pre-existing Hypercalcemia, Hypercalciuria, or Hypervitaminosis D.
  • Nephrolithiasis (kidney stones) or Nephrocalcinosis.
  • Severe renal impairment or Pseudohypoparathyroidism.

Caution and close monitoring of serum and urinary calcium levels are required for patients with sarcoidosis, impaired renal function, and those using cardiac glycosides. Use in pregnancy is generally contraindicated without documented evidence of a deficiency.

Overdose and Emergency Response

Overdose and when to seek help

Overdose of Depura (Cholecalciferol) results in Hypervitaminosis D, leading primarily to Hypercalcaemia, as described in official regulatory documents. This condition produces a recognized cluster of clinical manifestations.

Documented Manifestations and Severe Outcomes

Symptoms officially documented in regulatory labels include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, alongside systemic effects like weakness, apathy, polyuria, and excessive thirst (polydipsia). Severe toxicity carries the risk of life-threatening outcomes, including cardiac arrhythmia, coma, and irreversible damage to the renal system, such as nephrocalcinosis.

Required Emergency Actions

The regulatory guidance mandates that patients seek immediate medical attention if they experience any symptoms of overdose. All Vitamin D and calcium intake must be immediately discontinued. Emergency services should be contacted for severe presentations, such as collapse, seizure, or significant difficulty breathing. No specific antidote for Cholecalciferol overdose is known; therefore, the required management is strictly supportive, focusing on measures like rehydration and the use of specific pharmaceuticals to correct the documented hypercalcaemia.

Therapeutic Uses of Depura

What Depura Treats: Main Uses and Benefits

Depura (Cholecalciferol) is commonly used to address insufficient or low Vitamin D levels, which is considered relevant for overall systemic health. This therapy supports the body's mineral balance, which is considered relevant for bone integrity and function.

Core Therapeutic Contexts

Depura is primarily used to manage conditions resulting from prolonged deficiency, specifically the developmental disorder Rickets in children and Osteomalacia (bone softening) in adults, and as supportive therapy for Osteoporosis and Hypoparathyroidism. The medication is applied in addressing the risk factors in specific patient groups who are prone to deficiency, such as older adults, infants, and those with limited sun exposure.

This treatment helps address symptom clusters of deep bone pain, generalized muscle aches, and functional weakness linked to systemic imbalance. Depura may assist with supportive relief from the physical symptoms, contributing to improved comfort and stability during periods where symptoms interfere with daily functioning.

Quick Fact: Symptomatic Relief
Depura is used for managing symptom clusters related to bone fragility and systemic imbalance, supporting functional stability during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

Who Can and Cannot Use Depura? (Cholecalciferol)

Official regulatory information defines eligibility for Depura primarily based on the patient’s existing health status, particularly concerning calcium and kidney function.

Populations Contraindicated (Must Not Use)

Depura is formally contraindicated and must not be used in individuals with pre-existing conditions that affect calcium balance or cause severe organ dysfunction. These exclusions include patients with hypercalcaemia (high blood calcium) or hypervitaminosis D (excess Vitamin D) and those with severe renal impairment or a history of nephrolithiasis (kidney stones). Use is also prohibited for individuals with known hypersensitivity to Cholecalciferol or its components.

Restricted and Age-Specific Use

The medicine is generally permitted for use in adults, older adults, and the pediatric population. However, specific high-strength formulations are not recommended for use in children under 12 years. Use during pregnancy and lactation is generally allowed, but only if strictly avoiding overdosage, as advised in regulatory labeling. Caution is also required for patients with conditions like sarcoidosis, due to the risk of increased calcium levels.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions Affecting Depura Exposure

The regulatory profile notes two mechanisms that can reduce the body’s exposure to Depura (Cholecalciferol). Certain anticonvulsants, such as Phenytoin and Phenobarbital, are documented to increase the metabolic catabolism of Cholecalciferol, which may result in lower plasma levels. Separately, agents that interfere with fat absorption, including the bile acid sequestrant Cholestyramine and the weight-loss medication Orlistat, may impair the intestinal absorption of this fat-soluble compound. Corticosteroids and the herbal product St. John's wort are also documented to affect Cholecalciferol levels by similar mechanisms.

Interactions Affecting Systemic Calcium Balance and Toxicity

A primary pharmacodynamic risk involves additive effects on calcium regulation, potentially increasing the risk for hypercalcemia. Co-administration with Thiazide Diuretics or Calcium Supplements is documented to raise this risk. For patients taking Cardiac Glycosides (e.g., Digoxin), this hypercalcemia risk is significant as it may increase the potential for serious arrhythmia. A separate restriction concerns Aluminum-containing Antacids: Cholecalciferol increases the absorption of aluminum, posing a risk of aluminum retention, especially for patients with renal impairment. To manage this, the administration of Depura and these antacids must be temporally separated.

Mechanism of Action

How Depura Works: Mechanism of Action

Depura engages directly with core regulatory systems by acting as a selective modulator of defined receptor and enzyme systems. This interaction is the foundation of its pharmacodynamic profile, operating within domains that govern cellular excitability and signaling dynamics.

Altering Signal Transduction Pathways

Following target engagement, the drug operates within well-characterized molecular cascades to alter signal transduction. This mechanistic action influences the core signaling sequences, particularly in systems where specific transmitters or mediators dominate, thereby modifying the intracellular processes that propagate the signal.

Modulating Physiological Responses

By influencing these signaling dynamics, Depura acts to adjust the level of activity within specific pathways. This supports the regulation of processes driven by distinct signaling patterns, particularly those occurring in contexts of heightened pathway activation. The resulting system-level physiological adjustments are consistent with the drug's overall effect profile.

Dosage and Administration Information

How to use Depura

Depura (Cholecalciferol) is administered exclusively by the oral route, utilizing available dosage forms such as tablets, soft-gelatin capsules, or oral solutions. The official use of the medicine is structured into an initial correction phase followed by a sustained maintenance phase.


Official Dosing Regimens and Frequency

Dosing regimens are precisely defined in official prescribing information. For the treatment of deficiency in adults, a common pattern involves high-dose administration, such as 50,000 International Units (IU) taken once weekly for a finite period of approximately 6 to 8 weeks. Following correction, use transitions to a long-term maintenance schedule, which typically involves a daily dose ranging from 600 IU to 4,000 IU. Pediatric use often relies on the oral drop formulation at lower daily doses, such as 400 IU.


Administration Conditions

A key procedural requirement is that Depura should be taken with food or the main meal of the day. This instruction is based on the compound's fat-soluble nature, which optimizes its absorption. When administering the oral solution or drops, official labeling mandates the use of the calibrated dosing device provided with the product to ensure the accuracy of the prescribed volume. Solid dosage forms such as soft-gel capsules must be swallowed whole. If a dose is missed, regulatory instructions advise skipping the missed dose and resuming the regular schedule, rather than taking two doses simultaneously.

Recent Clinical Evidence

Research evidence / Overview of studies for Depura (Cholecalciferol)

The research landscape for Depura is defined by its role as an essential nutrient, with studies focusing on its function in calcium and phosphate balance. The available evidence, as summarized by regulatory bodies and major systematic reviews, focuses primarily on the clinical evaluation of cholecalciferol for low blood levels of vitamin D and for conditions that are characterized by this deficiency.


Evidence for Correcting Vitamin D Deficiency

Depura was evaluated in numerous short-term, controlled clinical trials (RCTs). These studies were designed to research the influence of the substance on the body's vitamin D status. Researchers primarily monitored the serum concentration of 25-hydroxyvitamin D (25( OH) D), the key biomarker. Studies reported measurements showing that the administration of cholecalciferol was associated with measurable increases in the 25( OH) D biomarker concentrations. While the measured change in the 25( OH) D biomarker is well-documented, the optimal target level for achieving general, non-skeletal health outcomes is still a subject of scientific exploration.


Evidence for Bone Mineralization and Health

Foundational research for Depura has explored its use in conditions characterized by classic vitamin D deficiency that affect the skeletal system: Rickets in children and Osteomalacia in adults. Research explored changes in radiographic lesions and the normalization of blood parameters like calcium and phosphate. The evidence contributes to understanding the outcomes related to systemic or functional imbalance that occur alongside severe deficiency. Reports describe patterns of biochemical normalization and structural healing in the bone, which were tracked during the studies.


Evidence for Osteoporosis and Fracture Risk Management

The most extensive body of evidence involves research examining Depura's role in the management of Osteoporosis and its evaluation in fracture risk reduction studies. Researchers monitored skeletal endpoints over extended time periods, often 1 to 5 years or more, tracking the incidence of fractures and changes in Bone Mineral Density (BMD). Findings were mixed across various systematic reviews and meta-analyses concerning a consistent pattern related to the reduction of all fracture types across different study cohorts. The specific contribution of Depura alone is sometimes difficult to isolate, as many key trials utilized simultaneous administration of calcium.

Key Studies & References

  1. Cholecalciferol Drug Information (MedlinePlus)
  2. Clinical Guideline: Vitamin D deficiency in children and adolescents (NICE Guideline NG132)

Frequently Asked Questions (FAQ)

Common questions about Depura (FAQ)

Q: Does Depura cause weight gain?

Official regulatory documents typically list a number of gastrointestinal effects related to possible toxicity. These reported symptoms include loss of appetite and sometimes weight loss. Weight gain is not described as a commonly reported or listed adverse reaction in the official product safety information.

Q: What are the signs that Depura is actually working?

The drug is authorized for the treatment or prevention of deficiency, which is confirmed by laboratory testing. Therefore, official sources state that the evidence of the drug 'working' is primarily based on achieving desired blood levels of 25-hydroxyvitamin D, the key biomarker. It is not typically associated with noticeable, immediate changes in general symptoms for the patient.

Q: Is Depura addictive or habit-forming?

According to official regulatory classifications, the active ingredient in Depura, Cholecalciferol (Vitamin D3), belongs to the vitamin drug class. It is not documented or classified as a controlled, addictive, or habit-forming substance.

Q: Are there specific times of day that Depura is better to take?

Regulatory guidance emphasizes that because the drug is fat-soluble, it must be taken with food or a main meal to ensure proper absorption in the body. However, official product information does not provide guidance on whether the medication should be taken in the morning, afternoon, or night.

Q: Can Depura be used by people with kidney issues?

Official labels clearly state that severe renal impairment is a contraindication (must not be used). For patients with less severe, impaired renal function, caution and monitoring are required. Official information indicates that alternative forms of the vitamin may be required or used with caution.

Q: How long does it take for Depura to leave my system?

Due to its fat-soluble nature, the drug’s metabolite, 25( OH) D, is known to remain detectable in the body for a long duration after administration. Official information notes that blood levels of the key marker, 25( OH) D, generally peak within 7 to 14 days after initiation.

Q: Is Depura safe for long-term use?

Long-term maintenance use at lower doses is a documented part of approved treatment regimens. However, official regulatory documents stress that any use of high-dose regimens must be for a set period of time under professional supervision. This is necessary for monitoring to manage the risk of toxicity.

Q: Do I need a special diet while taking Depura?

Regulatory documents advise that intake of foods containing natural or added calcium, phosphate, vitamin D, or grapefruit may need to be adjusted. This adjustment is often suggested to support the maintenance of the body's mineral balance, based on official advice.

Q: Is Depura available without a prescription?

Some low-strength formulations of the active ingredient, Cholecalciferol, are available without a prescription. Conversely, high-strength preparations or specific oral solutions are subject to regulatory oversight and may require a prescription.

Q: Can I use Depura while taking vitamins or supplements?

Official sources warn not to take other vitamin or mineral supplements that specifically contain calcium or vitamin D without first consulting a professional. This caution is issued to mitigate the risk of causing excessive blood levels of these substances.

Q: Is Depura considered a high-risk medication?

Regulatory sources note that the therapeutic index (the range between an effective dose and a toxic dose) can be narrow. Official sources indicate that the main serious safety concern is the risk of Hypervitaminosis D (toxicity), which necessitates close monitoring.

Q: Does stopping Depura suddenly cause any issues?

Stopping the medication is associated with the possibility of the underlying vitamin D deficiency the drug was intended to address returning. This deficiency, according to official information, can result in complications such as low blood calcium levels (hypocalcemia) and related bone diseases.

Q: Can Depura affect blood pressure?

Regulatory safety information links the serious condition of Hypervitaminosis D (toxicity) to potential complications, including the development of hypertension (high blood pressure).

Q: Is Depura used for anything other than its main approved condition?

Official drug labels list approved uses, which are generally restricted to the prevention and treatment of vitamin D deficiency and related bone conditions. Regulatory agencies do not provide information about unapproved uses (often called off-label uses).

Q: What should I look out for when I start taking Depura?

Regulatory documents detail the early symptoms of vitamin D intoxication (toxicity) to review, which include symptoms like weakness, fatigue, headache, loss of appetite, and constipation.

Q: Can Depura make certain health conditions worse?

Official regulatory labels list disease interactions and state that the use of the drug is contraindicated or requires close monitoring in patients with specific conditions. These conditions include hypercalcemia (high blood calcium), arrhythmia, or renal dysfunction.

Q: Does Depura interact with alcohol?

The active ingredient in Depura is generally reported in regulatory safety screening to have no known direct interaction with alcohol. However, individual circumstances mean professional consultation is generally suggested when reviewing consumption with any medication.

How should Depura be stored and disposed of?

How to Store and Dispose of Depura?

This section outlines the official requirements for storing and disposing of Depura (Cholecalciferol) as defined in regulatory labeling.

Storage Requirements

Depura must be stored at a temperature below 25 C and must not be frozen. To maintain product stability and quality, the medicine must be kept in the original outer carton to protect it from light and moisture. Keep the medicine out of the sight and reach of children at all times.

Disposal Instructions

Do not throw away unused or expired Depura via wastewater or household waste. The medicine must be disposed of in accordance with local requirements, which typically involves utilizing official community drug take-back programs or consulting a pharmacist for guidance on proper disposal methods.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Depura found in:

A-Z Index: